Characterizing heart tissue development in infants with congenital heart disease
Official title: Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development
Run by Emory University · NCT00243776 · Data updated 2026-11-12
This study looks at heart tissue from infants with congenital heart disease to see how it works differently than in adults, hoping to find better treatments for these conditions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | Any age to 20 Years |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | Emory University Academic / other |
| Locations | 1 site (Atlanta, Georgia) |
| Status | Recruiting |
| Started | April 2005 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | May 6, 2026 |
| Trial ID | NCT00243776 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are infants undergoing cardiopulmonary bypass surgery for congenital heart defects.
✕Probably not a fit
Patients with a history of prior cardiac surgery or atrial arrhythmias may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the molecular and cellular characteristics of cardiac tissue in infants undergoing surgery for congenital heart disease. Researchers will analyze small samples of heart tissue to understand how calcium ions regulate heart cell contraction differently in infants compared to adults. The study will also explore the development of human pluripotent stem cell-derived cardiomyocytes in a 3D environment to enhance their functional and metabolic maturation. By examining these differences, the study seeks to improve therapeutic approaches for congenital heart conditions.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for infants with congenital heart disease.
How similar studies have gone: While there have been studies on adult heart cells, this approach focusing on infant heart cells is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients undergoing cardiopulmonary bypass surgery * Patients undergoing surgery for repair of congenital heart disease such as ventricular septal defect or defective mitral or aortic valves. Exclusion Criteria: * Prior cardiac surgery * History of atrial fibrillation or other atrial arrhythmias prior to operation * History of heart failure
Where it's running
-
Emory University School of Medicine
Atlanta, Georgia, United States Recruiting
Study contacts
- Principal investigator: Michael E Davis, PhD — Emory University
- Study coordinator: Michael E Davis, PhD
- Email: medavis@emory.edu
- Phone: 404-727-9858
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
High intensity interval training for patients with congenital heart defects
This study is testing if a 12-week home workout program can help young people with certain heart defects exercise better and feel stronger.
-
Effects of stenting on exercise capacity in patients with certain congenital heart defects
This study is testing if a procedure to open blocked arteries can help people with certain heart defects, like d-TGA, ToF, and TA, exercise better.
-
Understanding heart issues in patients with congenital heart disease
This study is trying to understand what causes symptoms like shortness of breath and palpitations in people with congenital heart disease, especially those with Tetralogy of Fallot, by using remote heart monitoring.
-
Registry of patients with Tetralogy of Fallot using implantable defibrillators
This study is creating a national registry to track adult patients in France with Tetralogy of Fallot who have implantable defibrillators, to better understand their health over time.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates
A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.